CannabisNewsBreaks Archive - Page 378 of 429

TuesdayFeb 27, 2018 3:33 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO, Chief Research Officer Discuss Company’s Response to Opioid Epidemic

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was featured in an interview today by Proactive Investors. Chairman and CEO Stephen Van Deventer and chief research officer Dr. Harry Parekh discussed the company’s four programs: Sol-Gel, Nature Identical™, Dual Gene Therapy and Engineering Peptide Therapeutics. Among other topics, they discuss the rising rate of opioid overdoses and addiction, which the company’s planning to tackle utilizing its proprietary linker technology to engineer peptide therapeutics. “What's key about the technology is you cannot create tolerance to this treatment and you cannot overdose as well,” PreveCeutical chairman and CEO…

TuesdayFeb 27, 2018 11:28 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Completes Acquisition of ERS Holdings; Announces Private Placement of Convertible Debentures

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced the successful completion of its acquisition of ERS Holdings, LLC (“ERS”). ERS, a privately-held California company, has developed a patented technology called Ready-To-Infuse-Cannabis (“RTIC”) which covers the transformation of cannabis oil into powder for infusion into various food and beverage products. In addition, ERS has filed several continuation patents that would permit cannabis powder to be combined with other health and wellness products such as natural sleep-aids, cold medications and vitamins. Ross Franklin, co-inventor of the patent, has been appointed as the Director of Research and Development of ERS and…

TuesdayFeb 27, 2018 10:52 am

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary CEO Comments on Crypto Cowboy, Sun Pacific Holding Corp. (SNPW) Agreement

Global Payout, Inc. (OTC: GOHE) this morning announced that Crypto Cowboy, LLC, of which the company’s wholly owned subsidiary MoneyTrac Technology, Inc. ("MTRAC") has a 5% stake, has entered into an agreement with Sun Pacific Holding Corp (OTC: SNPW) to collaborate together to build, develop, and manage a private exchange for coin-based tokens. The companies also intend to launch Crypto Cowboys' first private initial coin offering ("ICO") backed by Sun Pacific's Sun Green Coin. "This agreement between Crypto Cowboy and Sun Pacific is an incredible example of the impact and influence blockchain technology is just beginning to demonstrate across a…

TuesdayFeb 27, 2018 10:22 am

CannabisNewsBreaks – EVIO, Inc. (EVIO) Releases Letter to Shareholders

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning issued a letter to shareholders detailing its recent corporate milestones, fiscal results and projections, financing efforts and key management additions. “It is an exciting time to be involved in the cannabis industry, which is expected to double in size again by 2021 as more states look to legalize both medical and recreational cannabis use,” the letter reads. “Despite the risks inherent in any evolving marketplace, and despite the political uncertainty with respect to marijuana’s legal…

TuesdayFeb 27, 2018 10:16 am

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Surpasses Million Dollar Mark, Achieves 300% YOY Sales Growth in February

PotNetwork Holding (OTC: POTN) this morning said that its wholly-owned subsidiary, Diamond CBD, Inc., exceeded $1 million dollars in sales during the first 15 days of February. Compared to the same period of last year, Diamond CBD’s sales have increased by 300%. In the past year, the subsidiary has brought to market over 15 recognizable CBD brands including products such as CBD oils, edible gummies and vape pens. Diamond CBD has recently unveiled its new product line targeting the nutritional supplements sector of the market with Meds BioTech. “Our objective throughout 2018 is consistent, solid and substantial growth. We are…

TuesdayFeb 27, 2018 9:51 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Enters LOI to Acquire Stake in MTH Development Group

Specialized holding company SinglePoint, Inc. (OTCQB: SING) this morning announced its entry into a Letter of Intent to acquire a $1 million stake in California cannabis cultivation firm MTH Development Group, further establishing its footprint in the Californian cannabis market. Per the update, this acquisition will be the first of its kind for SinglePoint, because MTH operates 4.7 acres of land zoned for cannabis cultivation. SinglePoint is currently in negotiations to complete similar investments in other states. “We are excited for this opportunity. Having been to the operation and seeing their proprietary cultivation procedures we feel this is a great…

TuesdayFeb 27, 2018 9:11 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Licensing Agreement with Biolog, Inc.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, this morning announced its entry into a definitive technology licensing agreement with Los Angeles-based, privately-held Biolog, Inc. Under the terms of this agreement, Lexaria will provide its patented DehydraTECH™ technology in an effort to empower a unique set of next-generation food and beverage cannabis infusion products to be sold in the United States. “The versatility of Lexaria's DehydraTECH™ technology is witnessed through its adoption to deliver vitamins in a nationally-available consumer product, or cannabinoids in many U.S. states,” Chris…

MondayFeb 26, 2018 2:49 pm

CannabisNewsBreaks – Earth Science Tech, Inc. (ETST) Focuses on Completing Key Projects in 2018

Science-based biotechnology company Earth Science Tech, Inc. (OTC: ETST) has set its sights on a momentous year in 2018 with many noteworthy tasks on the horizon. An article discussing the company reads: “Earth Science Tech, Inc. (OTC: ETST) is working toward an uplisting to the OTCQB Venture Market in early 2018. It has also retained counsel for a planned Regulation A+ Tier 2 round of financing, which the company hopes will raise an aggregate of $4 million (http://cnw.fm/nZR5W). The funds would be used to finance its planned projects in the new year and for general working capital (http://cnw.fm/8ovOR), with share…

MondayFeb 26, 2018 10:15 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Appoints Director of International Operations

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced its appointment of Dr. Maher Khaled to the position of director of international operations. Khaled bolsters the PreveCeutical team with more than a decade of experience in commercializing therapeutic and diagnostic technologies, most recently at UniQuest Pty Ltd. Moving forward, he will be involved in overseeing PreveCeutical’s development of therapeutic technologies, as well as managing the company’s ongoing operations in Australia, reviewing acquisition and licensing opportunities and leading commercialization efforts for its growing IP portfolio. “We are delighted to have Dr. Khaled as part of…

MondayFeb 26, 2018 9:29 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Licensing Agreement with Neutrisci International Inc. (TSX-V: NU) (OTCQB: NRXCF)

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said it has entered an agreement with NeutriSci International Inc. (TSX-V: NU) (OTCQB: NRXCF) resulting in NeutriSci now having 100% ownership of Ambarii Trade Corporation. Lexaria has also granted to NeutriSci an Intellectual Property License and Supply Agreement for the manufacturing and sale of CBD based products. Per the License Agreement, NeutriSci will remain focused on the development and sales of its existing and pipeline products that include Lexaria's technology for enhancing palatability and bioavailability of beneficial non-psychoactive cannabinoids. Lexaria will receive continuing royalty revenues from the sales generated by these products.…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks